Prediction of Pathological Stage is Inaccurate in Men with PSA Values above 20 ng/mL

European Urology

Volumn 52, Issue 5, 2007, Pages 1374-1380

  Gallina, Andrea ^a,c   Jeldres, Claudio ^a   Chun, Felix K H ^b   Shariat, Shahrokh F ^d   Briganti, Alberto ^c   Walz, Jochen ^a,b   Roehrborn, Claus G ^d   Saad, Fred ^a   Huland, Hartwig ^b   Graefen, Markus ^b   Montorsi, Francesco ^c   Karakiewicz, Pierre I ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF HAMBURG   (Germany)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Extreme PSA values; Partin stages; Prediction; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 34548843881     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.12.010     Document Type: Article

References (24)

1. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
2. Partin A., Mangold L., Lamm D., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
3. Steuber T., Graefen M., Haese A., et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 175 (2006) 939-944
4. Briganti A., Chun F.K., Salonia A., et al. A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Eur Urol 51 (2007) 112-120
5. Chun F.K., Steuber T., Erbersdobler A., et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 49 (2006) 820-826
6. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 98 (2006) 788-793
7. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 (2006) 1019-1026
8. Gleason D.F. Histologic grading and clinical staging of prostate carcinoma. In: Tannenbaum M. (Ed). Urologic Pathology: The Prostate (1977), Lea and Febiger, Philadelphia, PA 171-197
9. Blute M., Bergstralh E., Partin A., et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 164 (2000) 1591-1595
10. Augustin H., Eggert T., Wenske S., et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 171 (2004) 177-181
11. Bastide C., Kuefer R., Loeffler M., et al. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/mL. Prostate Cancer Prostatic Dis 9 (2006) 239-244
12. Hsu C.Y., Joniau S., and Van Poppel H. Radical prostatectomy for locally advanced prostate cancer: technical aspects of radical prostatectomy. EAU Update series 3 (2005) 90-97
13. Yamada A.H., Lieskovsky G., Petrovich Z., et al. Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Am J Clin Oncol 17 (1994) 277-285
14. Gerber G.S., Thisted R.A., Chodak G.W., et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 32 (1997) 385-390
15. Van den Ouden D., Hop W.C., and Schroder F.H. Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol 160 (1998) 1392-1397
16. Ward J.F., Slezak J.M., Blute M.L., et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95 (2005) 751-756
17. Van Poppel H., Vekemans K., Da Pozzo L., et al. Radical prostatectomy for locally advanced prostate cancer: results of a feasibility study (EORTC 30001). Eur J Cancer 42 (2006) 1062-1067
18. Hsu C.Y., Joniau S., Oyen R., et al. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 51 (2007) 121-129
19. Brandli D.W., Koch M.O., Foster R.S., et al. Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy. BJU Int 92 (2003) 19-22
20. Haukaas S., Halvorsen O., Daehlin L., et al. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?. BJU Int 97 (2006) 51-55
21. Nam R.K., Zhang W.W., Jewett M.A., et al. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res 11 (2005) 8391-8397
22. Nam R.K., Zhang W.W., Trachtenberg J., Jewett M.A., et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 1429-1437
23. Winkler M.H., Khan F.A., Kulinskaya E., et al. The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy. BJU Int 94 (2004) 812-815
24. Antunes A.A., Srougi M., Dall'Oglio M.F., et al. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. BJU Int 96 (2005) 1258-1263